Renoprotective mechanisms of pirfenidone in hypertension-induced renal injury: through anti-fibrotic and anti-oxidative stress pathways-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Renoprotective mechanisms of pirfenidone in hypertension-induced renal injury: through anti-fibrotic and anti-oxidative stress pathways

Published:2013 Issue:6 Volume:34 Page:309-319
ISSN:0388-6107
Container-title:Biomedical Research
language:en
Short-container-title:Biomed. Res.

Author:

JI Xu,NAITO Yukiko,WENG Huachun,MA Xiao,ENDO Kosuke,KITO Naoko,YANAGAWA Nariaki,YU Yang,LI Jie,IWAI Naoharu

Publisher

Biomedical Research Press

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference39 articles.

1. 1. Al-Bayati MA, Xie Y, Mohr FC, Margolin SB and Giri SN(2002) Effect of pirfenidone against vanadate-induced kidneyfibrosis in rats. Biochem pharm 64, 517–525.

2. 2. Arumugam TV, Shiels IA, Margolin SB, Taylor SM andBrown L (2002) Pirfenidone attenuates ischaemia-reperfusioninjury in the rat small intestine. Clin Exp Pharmacol physiol29, 996–1000.

3. 3. Border WA, Okuda S, Languino LR, Sporn MB and RuoslahtiE (1990) Suppression of experimental glomerulonephritis byantiserum against transforming growth factor beta 1. Nature346, 371–374.

4. 4. Bottinger EP and Bitzer M (2002) TGF-beta signaling in renaldisease. J Am Soc Nephrol 13, 2600–2610.

5. 5. Brook NR, Waller JR, Bicknell GR and Nicholson ML (2005)The experimental agent pirfenidone reduces pro-fibrotic geneexpression in a model of tacrolimus-induced nephrotoxicity.J Surg Res 125, 137–143.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pirfenidone inhibits TGF-β1-induced fibrosis via downregulation of Smad and ERK pathway in MDCK cells;Veterinary Research Communications;2024-08-12

2. Pirfenidone improves voiding function by suppressing bladder fibrosis in underactive bladder rats;European Journal of Pharmacology;2024-08

3. Pirfenidone inhibits TGF-β1-induced fibrosis via downregulation of Smad and ERK pathway in MDCK cells;2024-07-03

4. Fibrosis in Chronic Kidney Disease: Pathophysiology and Therapeutic Targets;Journal of Clinical Medicine;2024-03-25

5. Investigating the possible mechanisms of pirfenidone to be targeted as a promising anti-inflammatory, anti-fibrotic, anti-oxidant, anti-apoptotic, anti-tumor, and/or anti-SARS-CoV-2;Life Sciences;2022-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3